Kris Jacobs Vacancies Kris Jacobs Kris Jacobs Loading jobs... Stay updated Sign up to stay updated and find out how you can get involved. Email Address Data protection consent Read, watch, share Filter by - Any -BlogEventsExplainerFact sheetFeature storyInfographicInterviewIssue briefLetterNewsletterOpinion articlePhoto storyPress releaseReportReport seriesResearch articleSpeechSpotlightStatementTechnical briefTopic overviewVideo Letter | 30 March 2022 COVID-19 CSO letter to EU on the reported draft text of the TRIPS Waiver negotiation Technical brief | 30 March 2022 COVID-19 MSF comments on the reported draft text of the TRIPS Waiver negotiation Letter | 30 March 2022 COVID-19 United States of America US civil society letter to the President on COVID-19 Waiver leaked text Blog Blog | 24 March 2022 Tuberculosis The deadly gap in diagnosing children with tuberculosis Photograph by Jasňa Riegerová Press release Press release | 21 March 2022 Tuberculosis MSF responds to updated WHO guidelines for tuberculosis in children 3 min Photograph by Pirah Qasi Press release Press release | 17 March 2022 COVID-19 MSF responds to Medicines Patent Pool deal with 35 manufacturers to produce COVID-19 treatment nirmatrelvir/ritonavir 3 min Photograph by Regina Layug Rosero Press release Press release | 16 March 2022 COVID-19 MSF responds to potential compromise on the ‘TRIPS Waiver‘ 4 min Blog Blog | 10 March 2022 Tropical & neglected diseases Lassa Fever: Why a Pandemic-Potential Virus Is Still Neglected Load More
Letter | 30 March 2022 COVID-19 CSO letter to EU on the reported draft text of the TRIPS Waiver negotiation
Technical brief | 30 March 2022 COVID-19 MSF comments on the reported draft text of the TRIPS Waiver negotiation
Letter | 30 March 2022 COVID-19 United States of America US civil society letter to the President on COVID-19 Waiver leaked text
Photograph by Jasňa Riegerová Press release Press release | 21 March 2022 Tuberculosis MSF responds to updated WHO guidelines for tuberculosis in children 3 min
Photograph by Pirah Qasi Press release Press release | 17 March 2022 COVID-19 MSF responds to Medicines Patent Pool deal with 35 manufacturers to produce COVID-19 treatment nirmatrelvir/ritonavir 3 min
Photograph by Regina Layug Rosero Press release Press release | 16 March 2022 COVID-19 MSF responds to potential compromise on the ‘TRIPS Waiver‘ 4 min
Blog Blog | 10 March 2022 Tropical & neglected diseases Lassa Fever: Why a Pandemic-Potential Virus Is Still Neglected
